[
  {
    "turn": "3:haiku:1",
    "templates": [
      "profiled counts"
    ],
    "question": "How many patients and samples are in the MSK-CHORD Study?",
    "latency_s": 4.259172705933452,
    "sql_calls": 0,
    "llm_calls": 2
  },
  {
    "turn": "3:sonnet:1",
    "templates": [
      "profiled counts"
    ],
    "question": "How many patients and samples are in the MSK-CHORD Study?",
    "latency_s": 21.027111388742924,
    "sql_calls": 2,
    "llm_calls": 6
  },
  {
    "turn": "6:haiku:1",
    "templates": [
      "top genes"
    ],
    "question": "What are the top 5 most frequently mutated genes in the Osteosarcoma study from TARGET?",
    "latency_s": 17.694695530459285,
    "sql_calls": 3,
    "llm_calls": 6
  },
  {
    "turn": "6:sonnet:1",
    "templates": [
      "top genes"
    ],
    "question": "What are the top 5 most frequently mutated genes in the Osteosarcoma study from TARGET?",
    "latency_s": 26.65050865523517,
    "sql_calls": 3,
    "llm_calls": 7
  },
  {
    "turn": "7:haiku:1",
    "templates": [
      "top genes"
    ],
    "question": "What are the top 5 most frequently copy number altered genes in the Osteosarcoma study from TARGET?",
    "latency_s": 28.31136362813413,
    "sql_calls": 5,
    "llm_calls": 11
  },
  {
    "turn": "8:haiku:1",
    "templates": [
      "top genes"
    ],
    "question": "What are the top 5 most frequently altered genes in a structural variant in the Osteosarcoma study from TARGET?",
    "latency_s": 18.648123156279325,
    "sql_calls": 4,
    "llm_calls": 8
  },
  {
    "turn": "9:haiku:1",
    "templates": [
      "top genes"
    ],
    "question": "\"What are the top 5 frequently altered genes in the Osteosarcoma study from TARGET for mutations, copy numbers and SVs combined?\"",
    "latency_s": 32.340863328427076,
    "sql_calls": 4,
    "llm_calls": 11
  },
  {
    "turn": "8:sonnet:1",
    "templates": [
      "top genes"
    ],
    "question": "What are the top 5 most frequently altered genes in a structural variant in the Osteosarcoma study from TARGET?",
    "latency_s": 80.45272585749626,
    "sql_calls": 7,
    "llm_calls": 17
  },
  {
    "turn": "7:sonnet:1",
    "templates": [
      "top genes"
    ],
    "question": "What are the top 5 most frequently copy number altered genes in the Osteosarcoma study from TARGET?",
    "latency_s": 137.912033399567,
    "sql_calls": 13,
    "llm_calls": 16
  },
  {
    "turn": "11:haiku:1",
    "templates": [
      "top genes"
    ],
    "question": "What are the top 5 most frequently mutated genes in the MSK-CHORD Study?",
    "latency_s": 17.924767000600696,
    "sql_calls": 1,
    "llm_calls": 6
  },
  {
    "turn": "11:sonnet:1",
    "templates": [
      "top genes"
    ],
    "question": "What are the top 5 most frequently mutated genes in the MSK-CHORD Study?",
    "latency_s": 51.56623266078532,
    "sql_calls": 2,
    "llm_calls": 12
  },
  {
    "turn": "13:haiku:1",
    "templates": [
      "gene frequency"
    ],
    "question": "What percentage of patients in the MSK-CHORD Study have at least one TP53 mutation?",
    "latency_s": 10.927993010729551,
    "sql_calls": 1,
    "llm_calls": 4
  },
  {
    "turn": "9:sonnet:1",
    "templates": [
      "top genes"
    ],
    "question": "\"What are the top 5 frequently altered genes in the Osteosarcoma study from TARGET for mutations, copy numbers and SVs combined?\"",
    "latency_s": 203.50576697662473,
    "sql_calls": 16,
    "llm_calls": 23
  },
  {
    "turn": "13:sonnet:1",
    "templates": [
      "gene frequency"
    ],
    "question": "What percentage of patients in the MSK-CHORD Study have at least one TP53 mutation?",
    "latency_s": 83.7190922126174,
    "sql_calls": 7,
    "llm_calls": 19
  },
  {
    "turn": "19:haiku:1",
    "templates": [
      "top genes"
    ],
    "question": "What are the top 10 most frequently mutated genes across all cancer types in the MSK-CHORD Study?",
    "latency_s": 23.36365805566311,
    "sql_calls": 3,
    "llm_calls": 8
  },
  {
    "turn": "19:sonnet:1",
    "templates": [
      "top genes"
    ],
    "question": "What are the top 10 most frequently mutated genes across all cancer types in the MSK-CHORD Study?",
    "latency_s": 72.22583297640085,
    "sql_calls": 3,
    "llm_calls": 15
  },
  {
    "turn": "20:haiku:1",
    "templates": [
      "gene frequency"
    ],
    "question": "What percentage of colorectal cancer samples have KRAS mutations in the MSK-CHORD Study?",
    "latency_s": 16.30458363890648,
    "sql_calls": 1,
    "llm_calls": 6
  },
  {
    "turn": "20:sonnet:1",
    "templates": [
      "gene frequency"
    ],
    "question": "What percentage of colorectal cancer samples have KRAS mutations in the MSK-CHORD Study?",
    "latency_s": 48.038245959207416,
    "sql_calls": 3,
    "llm_calls": 10
  },
  {
    "turn": "26:haiku:1",
    "templates": [
      "profiled counts"
    ],
    "question": "What percentage of genomic events in the MSK-CHORD Study occur in genes that are off-panel (not covered by the sequencing panel used)?",
    "latency_s": 15.6774408724159,
    "sql_calls": 2,
    "llm_calls": 5
  },
  {
    "turn": "26:sonnet:1",
    "templates": [
      "profiled counts"
    ],
    "question": "What percentage of genomic events in the MSK-CHORD Study occur in genes that are off-panel (not covered by the sequencing panel used)?",
    "latency_s": 33.77948728762567,
    "sql_calls": 3,
    "llm_calls": 7
  },
  {
    "turn": "27:haiku:1",
    "templates": [
      "gene frequency"
    ],
    "question": "Is there a correlation between ERBB2 gene amplification and ERBB2 protein expression levels in breast cancer samples from the MSK-CHORD Study?",
    "latency_s": 144.0379887651652,
    "sql_calls": 19,
    "llm_calls": 18
  },
  {
    "turn": "28:haiku:1",
    "templates": [
      "gene frequency"
    ],
    "question": "\"What percentage of glioblastoma patients have alterations in RB pathway genes (CDKN2A, CDK4, RB1)?\"",
    "latency_s": 131.48377236910164,
    "sql_calls": 9,
    "llm_calls": 14
  },
  {
    "turn": "27:sonnet:1",
    "templates": [
      "gene frequency"
    ],
    "question": "Is there a correlation between ERBB2 gene amplification and ERBB2 protein expression levels in breast cancer samples from the MSK-CHORD Study?",
    "latency_s": 253.63514193706214,
    "sql_calls": 13,
    "llm_calls": 21
  },
  {
    "turn": "28:sonnet:1",
    "templates": [
      "gene frequency"
    ],
    "question": "\"What percentage of glioblastoma patients have alterations in RB pathway genes (CDKN2A, CDK4, RB1)?\"",
    "latency_s": 59.587975423783064,
    "sql_calls": 2,
    "llm_calls": 9
  },
  {
    "turn": "31:haiku:1",
    "templates": [
      "gene frequency"
    ],
    "question": "Which cancer types have the highest frequency of EGFR mutations across all TCGA Pan-Cancer Atlas studies?",
    "latency_s": 24.537992604076862,
    "sql_calls": 3,
    "llm_calls": 8
  },
  {
    "turn": "31:sonnet:1",
    "templates": [
      "gene frequency"
    ],
    "question": "Which cancer types have the highest frequency of EGFR mutations across all TCGA Pan-Cancer Atlas studies?",
    "latency_s": 45.86210121773183,
    "sql_calls": 2,
    "llm_calls": 8
  },
  {
    "turn": "32:haiku:1",
    "templates": [
      "gene frequency"
    ],
    "question": "What are the most frequent EGFR mutation variants in lung adenocarcinoma and what percentage are known hotspot mutations?",
    "latency_s": 63.9816876873374,
    "sql_calls": 8,
    "llm_calls": 18
  },
  {
    "turn": "32:sonnet:1",
    "templates": [
      "gene frequency"
    ],
    "question": "What are the most frequent EGFR mutation variants in lung adenocarcinoma and what percentage are known hotspot mutations?",
    "latency_s": 98.63275762088597,
    "sql_calls": 15,
    "llm_calls": 19
  },
  {
    "turn": "35:haiku:1",
    "templates": [
      "gene frequency"
    ],
    "question": "Do samples with TP53 truncating mutations have significantly lower TP53 mRNA expression compared to wild-type samples?",
    "latency_s": 78.10106683708727,
    "sql_calls": 10,
    "llm_calls": 18
  },
  {
    "turn": "35:sonnet:1",
    "templates": [
      "gene frequency"
    ],
    "question": "Do samples with TP53 truncating mutations have significantly lower TP53 mRNA expression compared to wild-type samples?",
    "latency_s": 186.28678124584258,
    "sql_calls": 15,
    "llm_calls": 20
  },
  {
    "turn": "40:haiku:1",
    "templates": [
      "top genes"
    ],
    "question": "What are the most frequently altered genes in KRAS wild-type lung adenocarcinoma patients?",
    "latency_s": 69.00051254592836,
    "sql_calls": 10,
    "llm_calls": 17
  },
  {
    "turn": "42:haiku:1",
    "templates": [
      "gene frequency"
    ],
    "question": "What percentage of endometrial cancer patients have co-occurring oncogenic mutations in both KRAS and NRAS?",
    "latency_s": 42.838897401466966,
    "sql_calls": 4,
    "llm_calls": 11
  },
  {
    "turn": "40:sonnet:1",
    "templates": [
      "top genes"
    ],
    "question": "What are the most frequently altered genes in KRAS wild-type lung adenocarcinoma patients?",
    "latency_s": 162.9269585032016,
    "sql_calls": 7,
    "llm_calls": 18
  },
  {
    "turn": "43:haiku:1",
    "templates": [
      "gene frequency"
    ],
    "question": "\"In samples with both KRAS and NRAS mutations, what is the distribution of variant allele frequencies suggesting clonal vs subclonal events?\"",
    "latency_s": 62.2869164198637,
    "sql_calls": 5,
    "llm_calls": 10
  },
  {
    "turn": "44:haiku:1",
    "templates": [
      "gene frequency"
    ],
    "question": "What percentage of endometrial cancer samples have hypermutation (>5000 mutations) and how does this correlate with histological subtype?",
    "latency_s": 69.44337602518499,
    "sql_calls": 12,
    "llm_calls": 19
  },
  {
    "turn": "43:sonnet:1",
    "templates": [
      "gene frequency"
    ],
    "question": "\"In samples with both KRAS and NRAS mutations, what is the distribution of variant allele frequencies suggesting clonal vs subclonal events?\"",
    "latency_s": 121.2283974494785,
    "sql_calls": 7,
    "llm_calls": 14
  },
  {
    "turn": "45:haiku:1",
    "templates": [
      "top genes"
    ],
    "question": "What are the most frequently mutated genes in copy-number high subtype endometrial cancers compared to other subtypes?",
    "latency_s": 78.92083080112934,
    "sql_calls": 17,
    "llm_calls": 21
  },
  {
    "turn": "44:sonnet:1",
    "templates": [
      "gene frequency"
    ],
    "question": "What percentage of endometrial cancer samples have hypermutation (>5000 mutations) and how does this correlate with histological subtype?",
    "latency_s": 118.64406217820942,
    "sql_calls": 11,
    "llm_calls": 18
  },
  {
    "turn": "46:haiku:1",
    "templates": [
      "gene frequency"
    ],
    "question": "Which cancer types show the highest frequency of BRAF V600E mutations across all TCGA Pan-Cancer Atlas studies?",
    "latency_s": 48.3275146856904,
    "sql_calls": 6,
    "llm_calls": 13
  },
  {
    "turn": "45:sonnet:1",
    "templates": [
      "top genes"
    ],
    "question": "What are the most frequently mutated genes in copy-number high subtype endometrial cancers compared to other subtypes?",
    "latency_s": 116.67096100188792,
    "sql_calls": 6,
    "llm_calls": 14
  },
  {
    "turn": "46:sonnet:1",
    "templates": [
      "gene frequency"
    ],
    "question": "Which cancer types show the highest frequency of BRAF V600E mutations across all TCGA Pan-Cancer Atlas studies?",
    "latency_s": 103.33280877768993,
    "sql_calls": 6,
    "llm_calls": 12
  },
  {
    "turn": "48:haiku:1",
    "templates": [
      "gene frequency"
    ],
    "question": "\"What is the concordance between ERBB2 copy number amplification, mRNA overexpression, and protein overexpression in breast cancer?\"",
    "latency_s": 41.52799015305936,
    "sql_calls": 7,
    "llm_calls": 12
  },
  {
    "turn": "42:sonnet:1",
    "templates": [
      "gene frequency"
    ],
    "question": "What percentage of endometrial cancer patients have co-occurring oncogenic mutations in both KRAS and NRAS?",
    "latency_s": 140.84354831278324,
    "sql_calls": 0,
    "llm_calls": null
  },
  {
    "turn": "48:sonnet:1",
    "templates": [
      "gene frequency"
    ],
    "question": "\"What is the concordance between ERBB2 copy number amplification, mRNA overexpression, and protein overexpression in breast cancer?\"",
    "latency_s": 103.11422765254974,
    "sql_calls": 7,
    "llm_calls": 12
  },
  {
    "turn": "52:haiku:1",
    "templates": [
      "top genes",
      "gene frequency"
    ],
    "question": "What is the most frequent mutation in the TP53 gene in the TCGA breast cancer study?",
    "latency_s": 24.051513800397515,
    "sql_calls": 3,
    "llm_calls": 9
  },
  {
    "turn": "52:sonnet:1",
    "templates": [
      "top genes",
      "gene frequency"
    ],
    "question": "What is the most frequent mutation in the TP53 gene in the TCGA breast cancer study?",
    "latency_s": 32.841105319559574,
    "sql_calls": 2,
    "llm_calls": 7
  },
  {
    "turn": "58:sonnet:1",
    "templates": [
      "gene frequency"
    ],
    "question": "In the \u201cPan-cancer analysis of whole genomes\u201d study what is the survival difference and the corresponding statistical significance between patients with mutations in both TP53 and KRAS versus patients with only a KRAS mutation?",
    "latency_s": 132.86206309497356,
    "sql_calls": 7,
    "llm_calls": 13
  },
  {
    "turn": "58:haiku:1",
    "templates": [
      "gene frequency"
    ],
    "question": "In the \u201cPan-cancer analysis of whole genomes\u201d study what is the survival difference and the corresponding statistical significance between patients with mutations in both TP53 and KRAS versus patients with only a KRAS mutation?",
    "latency_s": 58.83513125963509,
    "sql_calls": 8,
    "llm_calls": 13
  },
  {
    "turn": "60:haiku:1",
    "templates": [
      "top genes"
    ],
    "question": "In the Breast Invasive Carcinoma TCGA study what are the top 5 down-regulated genes in TP53 mutated samples compared to non-mutated ones?",
    "latency_s": 29.571028700098395,
    "sql_calls": 2,
    "llm_calls": 9
  },
  {
    "turn": "60:sonnet:1",
    "templates": [
      "top genes"
    ],
    "question": "In the Breast Invasive Carcinoma TCGA study what are the top 5 down-regulated genes in TP53 mutated samples compared to non-mutated ones?",
    "latency_s": 140.61817012168467,
    "sql_calls": 5,
    "llm_calls": 12
  },
  {
    "turn": "65:haiku:1",
    "templates": [
      "top genes"
    ],
    "question": "What is the average tumor mutational burden of breast cancer patients who have at least two of the five most frequently mutated genes and how does this compare to the average TMB of all patients?",
    "latency_s": 54.86371509172022,
    "sql_calls": 7,
    "llm_calls": 13
  },
  {
    "turn": "65:sonnet:1",
    "templates": [
      "top genes"
    ],
    "question": "What is the average tumor mutational burden of breast cancer patients who have at least two of the five most frequently mutated genes and how does this compare to the average TMB of all patients?",
    "latency_s": 84.97575356252491,
    "sql_calls": 8,
    "llm_calls": 13
  },
  {
    "turn": "69:haiku:1",
    "templates": [
      "gene frequency"
    ],
    "question": "Which patients have a TP53 G199V mutation? Which are somatic vs germline?",
    "latency_s": 16.735654547810555,
    "sql_calls": 2,
    "llm_calls": 5
  },
  {
    "turn": "70:haiku:1",
    "templates": [
      "gene frequency"
    ],
    "question": "In MSS colorectal cancer, what is the frequency of BRAF oncogenic mutations (as defined by OncoKB)? Use the 2017 MSK study for this. Can you give me a table of all these mutations, with frequency, count and denominator?",
    "latency_s": 46.97006112150848,
    "sql_calls": 13,
    "llm_calls": 17
  },
  {
    "turn": "69:sonnet:1",
    "templates": [
      "gene frequency"
    ],
    "question": "Which patients have a TP53 G199V mutation? Which are somatic vs germline?",
    "latency_s": 164.70053609088063,
    "sql_calls": 7,
    "llm_calls": 12
  },
  {
    "turn": "73:haiku:1",
    "templates": [
      "gene frequency"
    ],
    "question": "What is the frequency of TP53 mutations in lung cancer?",
    "latency_s": 28.51086981035769,
    "sql_calls": 5,
    "llm_calls": 10
  },
  {
    "turn": "73:sonnet:1",
    "templates": [
      "gene frequency"
    ],
    "question": "What is the frequency of TP53 mutations in lung cancer?",
    "latency_s": 45.641331581398845,
    "sql_calls": 3,
    "llm_calls": 10
  },
  {
    "turn": "70:sonnet:1",
    "templates": [
      "gene frequency"
    ],
    "question": "In MSS colorectal cancer, what is the frequency of BRAF oncogenic mutations (as defined by OncoKB)? Use the 2017 MSK study for this. Can you give me a table of all these mutations, with frequency, count and denominator?",
    "latency_s": 104.75544479675591,
    "sql_calls": 9,
    "llm_calls": 15
  },
  {
    "turn": "74:haiku:1",
    "templates": [
      "top genes"
    ],
    "question": "What are the most mutated genes in lung cancer?",
    "latency_s": 30.588995123282075,
    "sql_calls": 6,
    "llm_calls": 11
  },
  {
    "turn": "76:haiku:1",
    "templates": [
      "gene frequency"
    ],
    "question": "Are TP53 mutations clinically actionable?",
    "latency_s": 5.142441552132368,
    "sql_calls": 0,
    "llm_calls": 1
  },
  {
    "turn": "76:sonnet:1",
    "templates": [
      "gene frequency"
    ],
    "question": "Are TP53 mutations clinically actionable?",
    "latency_s": 6.5665732230991125,
    "sql_calls": 0,
    "llm_calls": 1
  },
  {
    "turn": "74:sonnet:1",
    "templates": [
      "top genes"
    ],
    "question": "What are the most mutated genes in lung cancer?",
    "latency_s": 78.8722157087177,
    "sql_calls": 4,
    "llm_calls": 12
  },
  {
    "turn": "85:haiku:1",
    "templates": [
      "profiled counts",
      "gene frequency"
    ],
    "question": "generate a oncoprint of kras, stk11, keap1, tp53 alterations stratified by smoking status in lung adenocarcinoma from the mskcc clincogenomic sequencing cohort. Please only select oncogenic somatic alterations and remove samples with unknown smoking status",
    "latency_s": 72.64617978967726,
    "sql_calls": 0,
    "llm_calls": 4
  },
  {
    "turn": "85:sonnet:1",
    "templates": [
      "profiled counts",
      "gene frequency"
    ],
    "question": "generate a oncoprint of kras, stk11, keap1, tp53 alterations stratified by smoking status in lung adenocarcinoma from the mskcc clincogenomic sequencing cohort. Please only select oncogenic somatic alterations and remove samples with unknown smoking status",
    "latency_s": 171.02768353931606,
    "sql_calls": 7,
    "llm_calls": 20
  },
  {
    "turn": "92:haiku:1",
    "templates": [
      "gene frequency"
    ],
    "question": "what is the most prevalent TP53 mutation in uterine cancer that is not a point mutation",
    "latency_s": 48.35074480250478,
    "sql_calls": 8,
    "llm_calls": 14
  },
  {
    "turn": "92:sonnet:1",
    "templates": [
      "gene frequency"
    ],
    "question": "what is the most prevalent TP53 mutation in uterine cancer that is not a point mutation",
    "latency_s": 72.50779221206903,
    "sql_calls": 3,
    "llm_calls": 8
  },
  {
    "turn": "101:haiku:1",
    "templates": [
      "top genes"
    ],
    "question": "List the top 20 mutated genes in study nbl_msk_2023.",
    "latency_s": 12.914761820808053,
    "sql_calls": 2,
    "llm_calls": 4
  },
  {
    "turn": "101:sonnet:1",
    "templates": [
      "top genes"
    ],
    "question": "List the top 20 mutated genes in study nbl_msk_2023.",
    "latency_s": 78.89241127669811,
    "sql_calls": 2,
    "llm_calls": 10
  },
  {
    "turn": "110:haiku:1",
    "templates": [
      "gene frequency"
    ],
    "question": "Can you explore the difference in mutation frequency between left-sided and right-sided CRC?",
    "latency_s": 45.90882683172822,
    "sql_calls": 4,
    "llm_calls": 11
  },
  {
    "turn": "110:sonnet:1",
    "templates": [
      "gene frequency"
    ],
    "question": "Can you explore the difference in mutation frequency between left-sided and right-sided CRC?",
    "latency_s": 101.85556095838547,
    "sql_calls": 7,
    "llm_calls": 12
  },
  {
    "turn": "116:haiku:1",
    "templates": [
      "gene frequency"
    ],
    "question": "What are the frequencies of different KRAS mutations in TCGA PanCan Lung Adenocarcinoma?",
    "latency_s": 19.40836711227894,
    "sql_calls": 2,
    "llm_calls": 7
  },
  {
    "turn": "117:haiku:1",
    "templates": [
      "gene frequency"
    ],
    "question": "What cancer types in MSK-IMPACT have mutations in TP53?",
    "latency_s": 17.38782668299973,
    "sql_calls": 1,
    "llm_calls": 6
  },
  {
    "turn": "116:sonnet:1",
    "templates": [
      "gene frequency"
    ],
    "question": "What are the frequencies of different KRAS mutations in TCGA PanCan Lung Adenocarcinoma?",
    "latency_s": 64.35622331127524,
    "sql_calls": 7,
    "llm_calls": 15
  },
  {
    "turn": "117:sonnet:1",
    "templates": [
      "gene frequency"
    ],
    "question": "What cancer types in MSK-IMPACT have mutations in TP53?",
    "latency_s": 53.1552244219929,
    "sql_calls": 1,
    "llm_calls": 9
  },
  {
    "turn": "123:haiku:1",
    "templates": [
      "gene frequency"
    ],
    "question": "In TCGA lower grade glioma, show me samples that are TP53 mutant or EGFR amplified.",
    "latency_s": 40.55617556348443,
    "sql_calls": 4,
    "llm_calls": 10
  },
  {
    "turn": "123:sonnet:1",
    "templates": [
      "gene frequency"
    ],
    "question": "In TCGA lower grade glioma, show me samples that are TP53 mutant or EGFR amplified.",
    "latency_s": 48.530043037608266,
    "sql_calls": 0,
    "llm_calls": 3
  },
  {
    "turn": "133:haiku:1",
    "templates": [
      "gene frequency"
    ],
    "question": "What are the EGFR mutation frequencies across cancer types in the MSK-IMPACT 50K study?",
    "latency_s": 17.3047461155802,
    "sql_calls": 1,
    "llm_calls": 6
  },
  {
    "turn": "133:sonnet:1",
    "templates": [
      "gene frequency"
    ],
    "question": "What are the EGFR mutation frequencies across cancer types in the MSK-IMPACT 50K study?",
    "latency_s": 133.81272304803133,
    "sql_calls": 4,
    "llm_calls": 16
  },
  {
    "turn": "136:haiku:1",
    "templates": [
      "gene frequency"
    ],
    "question": "In the TCGA Breast Cancer study, do TP53 mutations and high MYC expression co-occur or are they mutually exclusive?",
    "latency_s": 47.861691968515515,
    "sql_calls": 4,
    "llm_calls": 13
  },
  {
    "turn": "136:sonnet:1",
    "templates": [
      "gene frequency"
    ],
    "question": "In the TCGA Breast Cancer study, do TP53 mutations and high MYC expression co-occur or are they mutually exclusive?",
    "latency_s": 114.03056779131293,
    "sql_calls": 7,
    "llm_calls": 13
  },
  {
    "turn": "140:haiku:1",
    "templates": [
      "gene frequency"
    ],
    "question": "what's the frequency of different idh1 mutations in glioma vs cholangio vs chndrosarcoma? Give me a link to compare the frequency of the specific IDH1 mutations in those cancer types.",
    "latency_s": 29.83970263414085,
    "sql_calls": 3,
    "llm_calls": 8
  },
  {
    "turn": "140:sonnet:1",
    "templates": [
      "gene frequency"
    ],
    "question": "what's the frequency of different idh1 mutations in glioma vs cholangio vs chndrosarcoma? Give me a link to compare the frequency of the specific IDH1 mutations in those cancer types.",
    "latency_s": 157.5027785655111,
    "sql_calls": 12,
    "llm_calls": 14
  }
]